← Leaderboards
Adam Chervin
Immuven, Inc.
$2,201,767
Attributed
$2,350,278
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2011–14$2M$1.5M$1M$500K$0
'11
'12
'13
'14
Funding mix
By agency
NIH$2,350,278 · 4
By mechanism
R44$1,683,417 · 1
R43$448,552 · 2
R41$218,309 · 1
Top collaborators
- David M Kranz1 shared
Others in their field
Top investigators on “Legal Patent”
- Richard J. Whitley · University Of Alabama At Birmingham$37,499,995
- Bala Raja · Luminostics, Inc.$28,624,460
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Michael A Caligiuri · Ohio State University$19,428,493
- Michael Welch · Washington University$18,835,712
- Chang-Guo Zhan · University Of Kentucky$18,435,907
Research focus
Legal PatentFoundationsTechnologyUniversitiesIllinoisLicensingProteinsT-Cell ReceptorYeastsAffinityEngineeringRightsPharmacologic SubstanceBasePharmaceutical PreparationsLung DiseasesNew TechnologyProtein EngineeringInterestLeadDisease ManagementDiagnosisAffectInnovation
Grant awards (5)
Engineering Cytolytic Effectors to Eliminate Virus-Infected and Cancer Cells$218,309
R41 · FY2014 · CA · contact PI
Soluble high-affinity T cell receptors prevent MRSA lethality$683,418
R44 · FY2013 · AI · contact PI
Soluble high-affinity T cell receptors prevent MRSA lethality$999,999
R44 · FY2012 · AI · contact PI
Ultrasensitive Detection Probes for Staphylococcus aureus Enterotoxins$297,023
R43 · FY2012 · AI · contact PI
Soluble high-affinity T cell receptors prevent MRSA lethality$151,529
R43 · FY2011 · AI · contact PI